文献速递乳腺癌支持与姑息治疗

诊断前经济困难与晚期癌症表现及筛查的中介作用

Financial Hardship Before Diagnosis: Influence on Late-Stage Cancer Presentation and the Role of Screening.
PubMed 文献 · J Clin Oncol · 2026-03-05

该病例对照研究基于SEER登记、信用报告和医疗理赔数据,纳入50148例成人实体瘤患者,发现诊断前经济困难与晚期诊断风险升高14%相关,在有组织筛查和可体检发现的癌种中关联更强,乳腺癌中70%的额外风险归因于未接受筛查。

要点

  • 诊断前经济困难与晚期癌症诊断风险升高14%相关(aRR 1.14)。
  • 有组织筛查癌种中关联更强(aRR 1.25),可体检发现癌种中aRR达1.44。
  • 乳腺癌中70%的晚期诊断额外风险归因于未接受筛查。

核心结论

  • 诊断前经济困难显著影响癌症诊断分期,尤其在有组织筛查和可体检发现的癌种中。
  • 乳腺癌中该关联大部分归因于缺乏筛查。
  • 经济困难是重要的健康社会决定因素,需针对性干预改善筛查可及性。

研究设计与样本

  • 病例对照研究,使用2014-2017年西部华盛顿SEER登记库中I至IV期实体瘤成人患者的去标识化链接记录。
  • 链接TransUnion信用报告数据和医疗理赔数据,涵盖多种癌症。
  • 经济困难定义为诊断前2年内至少有一条催收、坏账、房贷拖欠、税收留置、法拍、收回或破产记录。
  • 采用多变量对数二项回归评估经济困难与晚期诊断(III和IV期)的关联,并进行中介分析评估乳腺X线筛查在乳腺癌中的作用。

主要发现

  • 共纳入50148例癌症患者,平均年龄64岁,52%女性,85%非西班牙裔白人。
  • 30%的患者在诊断前经历经济困难。
  • 经济困难与晚期诊断概率升高14%相关(aRR 1.14 [95% CI, 1.11 to 1.17])。
  • 在有组织筛查的癌种中关联更强(aRR 1.25 [95% CI, 1.21 to 1.29]),在可体检发现的癌种中aRR为1.44(95% CI, 1.31 to 1.59),在无上述方案的癌种中无显著关联(aRR 1.00 [95% CI, 0.94 to 1.07]),各部位间存在差异。
  • 乳腺癌患者中,70%的晚期诊断额外风险归因于未接受筛查。

临床怎么用

  • 肿瘤内科医生应关注患者诊断前经济困难史,将其作为晚期诊断的风险因素。
  • 对有组织筛查和可体检发现的癌种,应针对性改善经济困难人群的筛查可及性。
  • 乳腺癌防控中,减少经济障碍以提高筛查接受率可能降低晚期诊断风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study investigates the relationship between prediagnosis financial hardship (FH) and cancer stage, and the mediating role of cancer screening in breast cancer. METHODS: This case-control study used linked, deidentified records from adult cancer patients diagnosed with stage I to IV solid tumors (2014-2017) from the Western Washington SEER registry, along with credit report data from TransUnion and health care claims, encompassing various cancers. FH was defined as at least one record of collections, charge-offs, delinquent mortgage payments, tax liens, foreclosures, repossessions, or bankruptcies within 2 years before diagnosis. We used multivariable log-binomial regression to assess the association between FH and late-stage diagnosis (stages III and IV) overall and by cancer screening category, and mediation analysis to evaluate the role of screening mammography in breast cancer. RESULTS: Among 50,148 patients with cancer (mean age 64 years, 52% female, 85% non-Hispanic White), 30% experienced FH before diagnosis, which was associated with a 14% higher probability of late-stage diagnosis (adjusted risk ratio [aRR], 1.14 [95% CI, 1.11 to 1.17]). This association was stronger for cancers with organized screening (aRR, 1.25 [95% CI, 1.21 to 1.29]) and those detectable by physical examinations (aRR, 1.44 [95% CI, 1.31 to 1.59]), but not for cancers without these protocols (aRR, 1.00 [95% CI, 0.94 to 1.07]), with variations among individual sites. Among patients with breast cancer, 70% of the increased risk of late-stage diagnosis was attributable to the nonreceipt of screening. CONCLUSION: FH significantly affects cancer stage at diagnosis, especially for cancers with organized screening and physical examinations. In breast cancer, this association is largely attributed to lack of screening. These findings underscore FH as an important social determinant of health and the need for targeted interventions to improve screening access.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Khor S, Yu K, Fedorenko CR, et al. Financial Hardship Before Diagnosis: Influence on Late-Stage Cancer Presentation and the Role of Screening. J Clin Oncol. 2026. PMID: 41785446. doi:10.1200/JCO-25-01360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。